Market Overview

Judge Allows Hidden Safety Studies to Be Used in NuvaRing Lawsuits

Share:

The NuvaRing Resource Center is the Web's largest source for information on NuvaRing side effects, research and legal news. Visit http://www.NuvaRing-Lawsuits.net

Orlando, FL (PRWEB) October 30, 2012

The National Center for Health Statistics reported on October 18th that use of IUD devices like NuvaRing are up as much as 700% since 1995. Unfortunately, experts have linked vaginal rings like NuvaRing to increased risks of blood clots. According to CBS News San Diego on September 21, 2012, the FDA has received more than 1,000 reports of blood clot injury or death in patients using NuvaRing.

Due to the number of NuvaRing lawsuits filed, the cases have been consolidated into a federal Multi-District Litigation court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. On September 5, 2012, the U.S. Panel on Multidistrict Litigation indicated that more than 1,000 cases have been filed so far.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using NuvaRing is urged to contact the NuvaRing Resource Center or speak with a lawyer about their legal options.

According to Yahoo News on October 26, 2012, U.S. Federal District Judge Rodney W. Sippel recently ordered that all studies into the safety of NuvaRing, which had previously been sealed by the drug maker and could harm their case, become available for trials which will start on May 6, 2013. http://news.yahoo.com/wright-schulte-llc-reports-judge-overseeing-federal-nuvaring-072629160.html

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

Last October, the FDA issued a report titled, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which showed vaginal ring contraceptives could increase the risks of blood clots by as much as 56%.

The NuvaRing Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the Resource Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on research, side effects and litigation news related to NuvaRing devices, or to speak with a lawyer, visit http://www.NuvaRing-Lawsuits.net.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebnuvaring-lawsuits/pulmonary-embolism/prweb10069151.htm

View Comments and Join the Discussion!
 
Loading...